Innovations in Treatments for Pelvic Floor Disorders: A Southwestern PFDN site

盆底疾病治疗的创新:西南 PFDN 网站

基本信息

项目摘要

Project Summary/Abstract The University of New Mexico’s clinical site has made major contributions to the current 2011-2016 PFDN cycle including innovative concept proposal design, translational research, involvement of UNM’s CTSC and minority recruitment. We have met the Network’s goal of conducting rigorous, multi-center trials to investigate the clinical and human aspects of pelvic floor disorders on women. We achieved our objectives to bring minority women to participate in Network trials and met or exceeded Network goals in the recruitment and retention of women to ongoing PFDN clinical trials. Our team is led by Dr. Rogers, MD, Principal Investigator (PI), and Dr. Komesu, MD (Alternate PI) both of whom have extensive experience in the design and conduct of multi-center randomized clinical trials, and have led major translational studies this cycle. Since joining the PFDN, UNM has added subsites at Sandoval Regional Medical Center (SRMC), the Albuquerque Veteran’s Administration (VA), UNM Westside Clinic (WSC), and expanded the participation of our private practice counterparts, Drs. Doak, MD and Dandade, MD. In addition, we have increased our urogynecologic clinical faculty to include Drs. Dunivan, MD (sub-site PI WSC), Jeppson MD (sub-site PI SRMC), and Cichowski MD (sub-site PI VA) all of whom have participated extensively in all aspects of the Network this cycle. In addition to our talented urogynecologic faculty, UNM brings a skilled multidisciplinary team of urologists, colo-rectal surgeons, gastroenterologist, physical therapists, imaging specialists, and PhD’s to participate in PFDN work. This proposal highlights the accomplishments of UNM clinical site this cycle and our plans for continued successful contributions to the PFDN in the upcoming cycle.
项目总结/摘要 新墨西哥州大学的临床研究中心为当前的2011-2016年PFDN做出了重大贡献 周期,包括创新概念提案设计,转化研究,UNM的CTSC的参与, 少数民族招聘。我们已经达到了该网络的目标,即进行严格的多中心试验, 女性骨盆底疾病的临床和人体方面。我们实现了目标, 少数民族妇女参加网络试验,达到或超过了网络的征聘目标, 保留女性参与正在进行的PFDN临床试验。我们的团队由首席研究员、医学博士Rogers领导 (PI),和Komesu博士,医学博士(候补PI),他们都在设计和执行方面拥有丰富的经验, 多中心随机临床试验,并领导了本周期的主要转化研究。自从加入 PFDN,UNM增加了桑多瓦尔地区医疗中心(SRMC)的子站点,阿尔伯克基退伍军人的 管理(VA),UNM西区诊所(WSC),并扩大了我们的私人执业的参与 同行,Doak博士和Dandade博士。此外,我们还增加了我们的泌尿妇科临床 教师包括Drs. Dunivan,MD(子站点PI WSC),Jeppson MD(子站点PI SRMC)和Cichowski MD (分网站PI VA)所有这些人都广泛参与了本周期网络的所有方面。除了 我们才华横溢的泌尿妇科学院,UNM带来了一个熟练的泌尿科医生,结肠直肠, 外科医生、胃肠病学家、物理治疗师、影像学专家和博士参与PFDN工作。 该提案强调了UNM临床研究中心在本周期取得的成就以及我们继续 在即将到来的周期中,成功地向人民国防军捐款。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yuko Margaret Komesu其他文献

Yuko Margaret Komesu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yuko Margaret Komesu', 18)}}的其他基金

Innovations in Treatments for Pelvic Floor Disorders: A Southwestern PFDN site
盆底疾病治疗的创新:西南 PFDN 网站
  • 批准号:
    9177906
  • 财政年份:
    2011
  • 资助金额:
    $ 1.82万
  • 项目类别:
Innovations in Treatments for Pelvic Floor Disorders: A Southwestern PFDN site
盆底疾病治疗的创新:西南 PFDN 网站
  • 批准号:
    10395271
  • 财政年份:
    2011
  • 资助金额:
    $ 1.82万
  • 项目类别:
Innovations in Treatments for Pelvic Floor Disorders: A Southwestern PFDN site
盆底疾病治疗的创新:西南 PFDN 网站
  • 批准号:
    9981447
  • 财政年份:
    2011
  • 资助金额:
    $ 1.82万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 1.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了